Toward a deeper understanding of the genetics of bipolar disorder

Frontiers in Psychiatry

Volumn 6, Issue AUG, 2015, Pages

  Kerner, Berit ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bipolar disorder; Common genomic polymorphisms; Deep sequencing; Genetic models of transmission; Rare variants

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

BIPOLAR DISORDER; FAMILY STUDY; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HERITABILITY; HUMAN; MUTATION RATE; NONHUMAN; POPULATION RESEARCH; PREVALENCE; PROTEIN PROCESSING; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84940485076     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2015.00105     Document Type: Review

References (75)

1. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press (1990).
2. Merikangas KR, Jin R, He J, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative. Arch Gen Psychiatry (2011) 68(3):241-51. doi: 10.1001/archgenpsychiatry.2011.12.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). 5th ed. Washington, DC: American Psychiatric Association (2013). doi:10.1176/appi.books.9780890425596.
4. Coryell W, Leon AC, Turvey C, Akiskal HS, Mueller T, Endicott J. The significance of psychotic features in manic episodes: a report from the NIMH collaborative study. J Affect Disord (2001) 67(1-3):79-88. doi:10.1016/S0165-0327(99)00024-5.
5. Kieseppä T, Partonen T, Haukka J, Kaprio J, Lönnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry (2004) 161:1814-21. doi:10.1176/appi.ajp.161.10.1814.
6. Song J, Bergen SE, Kuja-Halkola R, Larsson H, Landén M, Lichtenstein P. Bipolar disorder and its relation to major psychiatric disorders: a family-based study in the Swedish population. Bipolar Disord (2015) 17(2):184-93. doi:10.1111/bdi.12242.
7. Etain B, Aas M, Andreassen OA, Lorentzen S, Dieset I, Gard S, et al. Childhood trauma is associated with severe clinical characteristics of bipolar disorders. J Clin Psychiatry (2013) 74(10):991-8. doi:10.4088/JCP.13m08353.
8. Bratlien U, Øie M, Haug E, Møller P, Andreassen OA, Lien L, et al. Environmental factors during adolescence associated with later development of psychotic disorders-a nested case-control study. Psychiatry Res (2014) 215(3):579-85. doi:10.1016/j.psychres.2013.12.048.
9. Severance EG, Gressitt KL, Yang S, Stallings CR, Origoni AE, Vaughan C, et al. Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord (2014) 16(3):230-40. doi:10.1111/bdi.12159.
10. Rice J, Reich T, Andreasen NC, Endicott J, Van Eerdewegh M, Fishman R, et al. The familial transmission of bipolar illness. Arch Gen Psychiatry (1987) 44(5):441-7. doi:10.1001/archpsyc.1987.01800170063009.
11. Spence MA, Flodman PL, Sadovnick AD, Bailey-Wilson JE, Ameli H, Remick RA. Bipolar disorder: evidence for a major locus. Am J Med Genet (1995) 60(5):370-6. doi:10.1002/ajmg.1320600505.
12. Egeland JA, Gerhard DS, Pauls DL, Sussex JN, Kidd KK, Allen CR, et al. Bipolar affective disorders linked to DNA markers on chromosome 11. Nature (1987) 325(6107):783-7. doi:10.1038/325783a0.
13. Hodgkinson S, Sherrington R, Gurling H, Marchbanks R, Reeders S, Mallet J, et al. Molecular genetic evidence for heterogeneity in manic depression. Nature (1987) 325(6107):805-6. doi:10.1038/325805a0.
14. Risch N, Botstein D. A manic depressive history. Editorial. Nat Genet (1996) 12:351-3. doi:10.1038/ng0496-351.
15. Rüdin E. Zur Vererbung und Neuentstehung der Dementia praecox. Berlin: Springer Verlag OHG (1916).
16. Sham PC, Morton NE, Rice JP. Segregation analysis of the NIMH Collaborative study. Family data on bipolar disorder. Psychiatr Genet (1991) 2:175-84. doi:10.1097/00041444-199203000-00002.
17. Bucher KD, Elston RC, Green R, Whybrow P, Helzer J, Reich T, et al. The transmission of manic depressive illness-II. Segregation analysis of three sets of family data. J Psychiatr Res (1981) 16(1):65-78. doi:10.1016/0022-3956(81)90014-5.
18. Goldin LR, Gershon ES, Targum SD, Sparkes RS, McGinniss M. Segregation and linkage analyses in families of patients with bipolar, unipolar, and schizoaffective mood disorders. Am J Hum Genet (1983) 35(2):274-87.
19. Akiskal HS. The bipolar spectrum: research and clinical perspectives. Encephalocele (1995) 6:3-11.
20. Craddock N, Van Eerdewegh P, Reich T. Single major locus models for bipolar disorder are implausible. Am J Med Genet (1997) 74:18. doi:10.1002/(SICI)1096-8628(19970221)74:1<18::AID-AJMG4>3.0.CO;2-R.
21. Wilson DR. Evolutionary epidemiology and manic depression. Br J Med Psychol (1998) 71(Pt 4):375-95. doi:10.1111/j.2044-8341.1998.tb00999.x.
22. Wilson DR. Evolutionary epidemiology. Acta Biotheor (1992) 40:87-90. doi:10.1007/BF00046552.
23. Wilson E. Sociobiology: The New Synthesis. Cambridge, MA: Belknap/Harvard University Press (1975).
24. Cruz-Gordillo P, Fedrigo O, Wray GA, Babbitt CC. Extensive changes in the expression of the opioid genes between humans and chimpanzees. Brain Behav Evol (2010) 76(2):154-62. doi:10.1159/000320968.
25. Grossman SR, Andersen KG, Shlyakhter I, Tabrizi S, Winnicki S, Yen A, et al. Identifying recent adaptations in large-scale genomic data. Cell (2013) 152(4):703-13. doi:10.1016/j.cell.2013.01.035.
26. Ye CJ, Feng T, Kwon HK, Raj T, Wilson MT, Asinovski N, et al. Intersection of population variation and autoimmunity genetics in human T cell activation. Science (2014) 345(6202):1254665. doi:10.1126/science.1254665.
27. Jamison KR. Great wits and madness: more near allied? Br J Psychiatry (2011) 199(5):351-2. doi:10.1192/bjp.bp.111.100586.
28. Lynch M. Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci U S A (2010) 107(3):961-8. doi:10.1073/pnas.0912629107.
29. Livingstone FB. The wave of advance of an advantageous gene: the sickle cell gene in Liberia. Hum Biol (1960) 32:197-202.
30. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun (2010) 1:104. doi:10.1038/ncomms1104.
31. Collins F. Cystic fibrosis: molecular biology and therapeutic implication. Science (1992) 256:774-80. doi:10.1126/science.1375392.
32. Bray SM, Mulle JG, Dodd AF, Pulver AE, Wooding S, Warren ST. Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A (2010) 107(37):16222-7. doi:10.1073/pnas.1004381107.
33. Lander ES. The new genomics: global views of biology. Science (1996) 274(5287):536-9. doi:10.1126/science.274.5287.536.
34. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science (1996) 273(5281):1516-7. doi:10.1126/science.273.5281.1516.
35. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 40(9):1056-8. doi:10.1038/ng.209.
36. Kloiber S, Czamara D, Karbalai N, Müller-Myhsok B, Hennings J, Holsboer F, et al. ANK3 and CACNA1C-missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples. J Psychiatr Res (2012) 46(8):973-9. doi:10.1016/j.jpsychires.2012.04.017.
37. Hattori E, Toyota T, Ishitsuka Y, Iwayama Y, Yamada K, Ujike H, et al. Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet (2009) 150B(8):1110-7. doi:10.1002/ajmg.b.30941.
38. Kuo PH, Chuang LC, Liu JR, Liu CM, Huang MC, Lin SK, et al. Identification of novel loci for bipolar I disorder in a multi-stage genome-wide association study. Prog Neuropsychopharmacol Biol Psychiatry (2014) 51:58-64. doi:10.1016/j.pnpbp.2014.01.003.
39. Doyle GA, Lai AT, Chou AD, Wang MJ, Gai X, Rappaport EF, et al. Re-sequencing of ankyrin 3 exon 48 and case-control association analysis of rare variants in bipolar disorder type I. Bipolar Disord (2012) 14(8):809-21. doi:10.1111/bdi.12002.
40. Fiorentino A, O'Brien NL, Locke DP, McQuillin A, Jarram A, Anjorin A, et al. Analysis of ANK3 and CACNA1C variants identified in bipolar disorder whole genome sequence data. Bipolar Disord (2014) 16(6):583-91. doi:10.1111/bdi.12203.
41. Nesse RM. Ten questions for evolutionary studies of disease vulnerability. Evol Appl (2011) 4(2):264-77. doi:10.1111/j.1752-4571.2010.00181.x.
42. Kimura M. Stochastic processes and distribution of gene frequencies in natural selection. Cold Spring Harb Symp Quant Biol (1955) 22:33-53. doi:10.1101/SQB.1955.020.01.006.
43. Smeraldi E, Negri F, Heimbuch RC, Kidd KK. Familial patterns and possible modes of inheritance of primary affective disorders. J Affect Disord (1981) 3(2):173-82. doi:10.1016/0165-0327(81)90042-2.
44. Sturm RA, Larsson M. Genetics of human iris colour and patterns. Pigment Cell Melanoma Res (2009) 22(5):544-62. doi:10.1111/j.1755-148X.2009.00606.x.
45. White D, Rabago-Smith M. Genotype-phenotype associations and human eye color. J Hum Genet (2011) 56(1):5-7. doi:10.1038/jhg.2010.126.
46. Dubois L, Ohm Kyvik K, Girard M, Tatone-Tokuda F, Pérusse D, Hjelmborg J, et al. Genetic and environmental contributions to weight, height, and BMI from birth to 19 years of age: an international study of over 12,000 twin pairs. PLoS One (2012) 7(2):e30153. doi:10.1371/journal.pone.0030153.
47. Falconer DS. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet (1965) 29:51-76. doi:10.1111/j.1469-1809.1965.tb00500.x.
48. Rosenthal D, editor. The Genain Quadruplets. New York, NY: Basic Books (1963).
49. Gottesman II, Shields J, (with the assistance of D. R. Hanson). Schizophrenia: The Epigenetic Puzzle. Cambridge, MA: Cambridge University Press (1982).
50. Gottesman II, McGuffin P, Farmer AE. Clinical genetics as clues to the "real" genetics of schizophrenia (a decade of modest gains while playing for time). Schizophr Bull (1987) 13(1):23-47. doi:10.1093/schbul/13.1.23.
51. Mathews CA, Reus VI. Assortative mating in the affective disorders: a systematic review and meta-analysis. Compr Psychiatry (2001) 42(4):257-62. doi:10.1053/comp.2001.24575.
52. Baron M, Klotz J, Mendlewicz J, Rainer J. Multiple-threshold transmission of affective disorders. Arch Gen Psychiatry (1981) 38(1):79-84. doi:10.1001/archpsyc.1981.01780260081009.
53. Price RA, Kidd KK, Pauls DL, Gershon ES, Prusoff BA, Weissman MM, et al. Multiple threshold models for the affective disorders: the Yale-NIMH collaborative family study. J Psychiatr Res (1985) 19(4):533-46. doi:10.1016/0022-3956(85)90071-8.
54. Craddock N, Khodel V, Van Eerdewegh P, Reich T. Mathematical limits of multilocus models: the genetic transmission of bipolar disorder. Am J Hum Genet (1995) 57:690-702.
55. Kerner B, Rao AR, Christensen B, Dandekar S, Yourshaw M, Nelson SF. Rare genomic variants link bipolar disorder with anxiety disorders to CREB-regulated intracellular signaling pathways. Front Psychiatry (2013) 4:154. doi:10.3389/fpsyt.2013.00154.
56. Georgi B, Craig D, Kember RL, Liu W, Lindquist I, Nasser S, et al. Genomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolate. PLoS Genet (2014) 10(3):e1004229. doi:10.1371/journal.pgen.1004229.
57. Strauss KA, Markx S, Georgi B, Paul SM, Jinks RN, Hoshi T, et al. A population-based study of KCNH7 p.Arg394His and bipolar spectrum disorder. Hum Mol Genet (2014) 23(23):6395-406. doi:10.1093/hmg/ddu335.
58. Ament SA, Szelinger S, Glusman G, Ashworth J, Hou L, Akula N, et al. Rare variants in neuronal excitability genes influence risk for bipolar disorder. Proc Natl Acad Sci U S A (2015) 112(11):3576-81. doi:10.1073/pnas.1424958112.
59. Need AC, McEvoy JP, Gennarelli M, Heinzen EL, Ge D, Maia JM, et al. Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia. Am J Hum Genet (2012) 91(2):303-12. doi:10.1016/j.ajhg.2012.06.018.
60. Girard SL, Gauthier J, Noreau A, Xiong L, Zhou S, Jouan L, et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 43(9):860-3. doi:10.1038/ng.886.
61. Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet (2011) 43(9):864-8. doi:10.1038/ng.902.
62. Xu B, Ionita-Laza I, Roos JL, Boone B, Woodrick S, Sun Y, et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet (2012) 44(12):1365-9. doi:10.1038/ng.2446.
63. Takata A, Xu B, Ionita-Laza I, Roos JL, Gogos JA, Karayiorgou M. Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene. Neuron (2014) 82(4):773-80. doi:10.1016/j.neuron.2014.04.043.
64. Guipponi M, Santoni FA, Setola V, Gehrig C, Rotharmel M, Cuenca M, et al. Exome sequencing in 53 sporadic cases of schizophrenia identifies 18 putative candidate genes. PLoS One (2014) 9(11):e112745. doi:10.1371/journal.pone.0112745.
65. Ionita-Laza I, Xu B, Makarov V, Buxbaum JD, Roos JL, Gogos JA, et al. Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism. Proc Natl Acad Sci U S A (2014) 111(1):343-8. doi:10.1073/pnas.1309475110.
66. McCarthy SE, Gillis J, Kramer M, Lihm J, Yoon S, Berstein Y, et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry (2014) 19(6):652-8. doi:10.1038/mp.2014.29.
67. Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell (2013) 154(3):518-29. doi:10.1016/j.cell.2013.06.049.
68. Timms AE, Dorschner MO, Wechsler J, Choi KY, Kirkwood R, Girirajan S, et al. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families. JAMA Psychiatry (2013) 70(6):582-90. doi:10.1001/jamapsychiatry.2013.1195.
69. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature (2014) 506(7487):179-84. doi:10.1038/nature12929.
70. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature (2014) 506(7487):185-90. doi:10.1038/nature12975.
71. Ruderfer DM, Lim ET, Genovese G, Moran JL, Hultman CM, Sullivan PF, et al. No evidence for rare recessive and compound heterozygous disruptive variants in schizophrenia. Eur J Hum Genet (2015) 23(4):555-7. doi:10.1038/ejhg.2014.228.
72. Samocha KE, Robinson EB, Sanders SJ, Stevens C, Sabo A, McGrath LM, et al. A framework for the interpretation of de novo mutation in human disease. Nat Genet (2014) 46(9):944-50. doi:10.1038/ng.3050.
73. Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet (2014) 133(1):1-9. doi:10.1007/s00439-013-1358-4.
74. Geaghan M, Cairns MJ. MicroRNA and posttranscriptional dysregulation in psychiatry. Biol Psychiatry (2015) 78(4):231-9. doi:10.1016/j.biopsych.2014.12.009.
75. Giulivi C. Grand challenges in cellular biochemistry: the "next-gen" biochemistry. Front Chem (2014) 2:22. doi:10.3389/fchem.2014.00022.